Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO
NCT02091505
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Central Retinal Vein Occlusion
Interventions
DRUG:
Ranibizumab
Sponsor
Mie University